Ann Clin Microbiol 2025;29(1):2. Pulmonary infection caused by Segniliparus rugosus in a patient without systemic immunodeficiency but with bronchiectasis: first identification by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with whole-genome confirmation
| Antimicrobial agent | MIC (μg/mL) | Interpretation a) |
|---|---|---|
| Clarithromycin | > 32 | R |
| Amikacin | > 128 | R |
| Moxifloxacin | 2 | I |
| Linezolid | 16 | I |
| Streptomycin | 64 | N/A |
| Ciprofloxacin | ≤ 0.25 | S |
| Doxycycline | > 16 | R |
| Clofazimine | ≤ 0.25 | N/A |
| Trimethoprim/Sulfamethoxazole | ≤ 0.5/9.5 | S |
| Cefoxitin | 128 | R |
| Imipenem | 4 | S |
| Meropenem | 8 | I |
| Tobramycin | > 8 | R |
| Tigecycline | 4 | N/A |
a)Interpretations were made according to CLSI M62 for rapidly growing mycobacteria and are in line with those reported in previous case studies.
Abbreviations: MIC, minimum inhibitory concentration; R, resistant; I, intermediate; S, susceptible; N/A, no available breakpoint.